Search for Clinical Trial Results
Dermatofibrosarcoma - 38 Studies Found
Status | Study |
Completed |
Study Name: Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma Condition:
|
Completed |
Study Name: Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma Condition:
|
Completed |
Study Name: Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma Condition:
|
Completed |
Study Name: Imatinib Mesylate And Cyclophosphamide In Metronomic Administration: Dose Escalation Study Of Imatinib Mesylate Condition: Cancer Date: 2010-01-11 Interventions:
|
Terminated |
Study Name: Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue Sarcoma Condition: Sarcoma Date: 2008-08-22 Interventions:
|
Completed |
Study Name: Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas Condition:
Interventions: Drug: sunitinib malate |
Withdrawn |
Study Name: Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for Sarcoma Condition:
Date: 2006-06-07 Interventions:
|
Withdrawn |
Study Name: Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma Condition:
Date: 2006-06-07 Interventions:
|
Completed |
Study Name: Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases Condition: Life Threatening Diseases Date: 2005-09-09 Interventions: Drug: Imatinib mesylate |
Completed |
Study Name: Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans Condition: Dermatofibrosarcoma Protuberans Date: 2005-10-20 Interventions: Drug: imatinib mesylate 400 mg orally twice a day for 10 - 14 days |